Copenhagen Conference: Legal Perspectives on Synthetic Biology and Gene Editing

Join us at the Centre for Information and Innovation Law (CIIR) Faculty of Law, University of Copenhagen on 20 November, 2017 to discuss Legal Perspectives on Synthetic Biology and Gene Editing.

CALL FOR PAPERS

Emerging technologies in Synthetic Biology and Gene Editing offer incredible opportunities and promising solutions to some of the most urgent challenges faced by humanity, such as climate change, environmental protection, growing population, renewable energy and improved health care. But the emerging applications also raise exceptional ethical, legal and social questions.

This conference marks the final phase of the participation of the Copenhagen Biotech and Pharma Forum (CBPF) Research Group at the Centre for Information and Innovation Law (CIIR) in the cross-faculty research project BioSYNergy. In accordance with the goals of this large cross-faculty project on Synthetic Biology, the event explores legal perspectives on synthetic biology, systems biology and gene editing. Dealing with the legal responses to ethical and scientific challenges raised by emerging life science technology.

Taking into account the newest scientific developments and challenges, invited speakers will debate the legal implications of bio-pharma innovation in synthetic biology and gene editing. The conference will explore interfaces between Law, Science, Ethics and Commercialization of Bio-pharma innovation, with a focus on:

  • Gene editing regulation and applications
  • IP and Innovation
  • Licensing and Collaboration
  • Ethics and Human Enhancement

Abstracts (max 500 words) to be submitted until 13 September 2017 to: ana.nordberg@jur.ku.dk.

An edited volume based on the conference proceedings is being projected, selected speakers will be invited to contribute with a chapter (8,000-10,000 words incl. footnotes and bibliography).

Early expressions of interest or full paper submissions are most welcome.

Organizers: Postdoctoral Fellow Ana Nordberg; Prof. Timo Minssen; Research Fellow Jakob Wested

Contact: Ana.nordberg@jur.ku.dk

*Final date to be announced.

Registration:
The event is free to attend. Registration is mandatory. Please use this registration form no later than Thursday, 16 November 2017 at the latest.

Be Sociable, Share!
This entry was posted in Announcements, Bioethics, Biotechnology, Call for Abstracts, Clinical Research, Cloning, Enhancement, Global Health, GMO Food, Human Tissue, Intellectual Property, Pharmaceuticals, Public Health, Reproductive Technology, Stem Cells, Timo Minssen, Vaccines and tagged , , , , , by Timo Minssen. Bookmark the permalink.

About Timo Minssen

Timo Minssen is Professor of Biotechnology Law specializing in legal aspects of biomedical innovation at the University of Copenhagen (UCPH), Centre for Information & Innovation Law (CIIR), Denmark. Before joining UCPH, Timo graduated from law school in Göttingen (Germany) in 2001 and was trained in the German court system from 2002-2003. He also passed the Swedish “juris licentiate” (LL.Lic.) and “juris doctor” exams (LL.D.) and holds two IP- and Biotech- related masters degrees from the Universities of Uppsala and Lund (Sweden). In addition he worked for a Life Science company and for various law firms in Sweden and Germany. From 2007-2009 Timo was a stipendiary at the Max Planck Institute for Intellectual Property and Competition Law in Munich. He was also responsible for a course in comparative patent law at the Chicago-Kent College of Law (USA) and worked for the European Patent Office. At Lund University he is engaged as a teacher at the Faculty of Law and in interdisciplinary epigenetics research at the Pufendorf Institute for Advanced Studies. At UCPH he is co-leading CIIR’s Copenhagen Biotech & Pharma Forum and teaches international classes for both students and pharma professionals in EU-, Competition-, and Pharmaceutical Law and IPR. Timo is a frequent speaker on a variety of topics and has published extensively in comparative US and European patent law, EU- and Competition Law. In 2013-14, he was a Visiting Scholar at Harvard Law School's Petrie-Flom Center and at the University of Oxford. In 2016 he will be Visiting Research Fellow at the University of Cambridge.